Methylprednisolone vs IVIG in Autoimmune Encephalitis
High-dose intravenous methylprednisolone is the recommended first-line immunotherapy for autoimmune encephalitis, with IVIG or plasma exchange reserved as alternatives only when corticosteroids are contraindicated or not preferred 1.
First-Line Treatment Algorithm
Standard Approach (Non-Severe Presentation)
Start with high-dose IV methylprednisolone (IVMP) monotherapy once infection is ruled out based on CSF analysis 1. The recommended dosing is:
- 30 mg/kg IV over at least 30 minutes, repeated every 4-6 hours for 48 hours for high-dose therapy 2
- Standard dosing ranges from 10-40 mg/kg depending on disease severity 2
- Administer over several minutes to avoid cardiac arrhythmias (doses >0.5g should take >10 minutes) 2
IVIG or plasma exchange should be used as first-line monotherapy ONLY when:
- Corticosteroids are contraindicated (uncontrolled hypertension, uncontrolled diabetes, acute peptic ulcer, severe behavioral symptoms worsening with steroids) 1
- Corticosteroids are not preferred by the treating physician 1
Severe Presentation (Requires Combination from Start)
Initiate combination therapy with steroids PLUS IVIG or steroids PLUS plasma exchange immediately in patients with 1:
- Severe NMDAR-antibody encephalitis presentation
- New-onset refractory status epilepticus (NORSE)
- Severe dysautonomia
Choose IVIG over plasma exchange when:
Choose plasma exchange over IVIG when:
- Severe hyponatremia exists 1
- High thromboembolic risk (cancer, smoking, hypertension, diabetes, hyperlipidemia, hypercoagulable states) 1
- Associated brain or spinal demyelination 1
Sequential Treatment Strategy
If no clinical, radiological, or electrophysiological improvement by the end of the initial IVMP cycle, add IVIG or plasma exchange 1. This sequential approach is more common than upfront combination therapy, with 62% of experts choosing to add a different first-line agent if the initial treatment fails 1.
IVIG Dosing
- 300-600 mg/kg body weight (though this is the FDA-approved dose for immunodeficiency, not specifically AE) 3
- Infusion rate: Start at 0.5 mg/kg/min for 30 minutes, advance to 1 mg/kg/min for 30 minutes, then 2 mg/kg/min for 30 minutes, with maximum rate of 3.33 mg/kg/min 3
Plasma Exchange Dosing
- 5-10 sessions every other day 1
Evidence Quality and Nuances
The 2021 Journal of Neurology, Neurosurgery and Psychiatry guidelines represent the most authoritative consensus recommendations [1-1]. Corticosteroids are explicitly listed as the primary first-line option, with IVIG and plasma exchange positioned as alternatives or add-ons rather than equivalent choices.
Recent 2025 research from the German GENERATE network analyzing 388 patients found no significant difference in outcomes between IVMP + IVIG versus IVMP + plasma exchange for anti-NMDAR, anti-LGI1, or anti-CASPR2 encephalitis 4. However, a direct comparison showed slightly better mRS reduction with IVMP + plasma exchange in anti-NMDAR encephalitis specifically 4.
Critical Pitfalls to Avoid
Do not delay treatment waiting for antibody results - Start IVMP empirically once infection is excluded 1
Do not use IVIG as routine first-line monotherapy - Despite being effective, it is not the guideline-recommended initial approach unless steroids are contraindicated 1
Do not continue ineffective monotherapy beyond one treatment cycle - Add a second first-line agent if no improvement is seen 1
Ensure volume repletion before IVIG - Patients must not be volume depleted to minimize renal dysfunction risk 3
Monitor infusion rates carefully - Rapid IVMP administration (>0.5g in <10 minutes) can cause cardiac arrhythmias and arrest 2
Bridging and Maintenance Therapy
After acute treatment, initiate bridging therapy with gradual oral prednisone taper OR monthly IV immunoglobulin OR monthly IV methylprednisolone 1.
Second-Line Escalation
If no clinical or radiological improvement 2-4 weeks after combined first-line therapy, escalate to second-line agents: